Familial Papillary Thyroid Carcinoma-4 Members from a Single Family

被引:0
作者
Azaria, Swarna [1 ]
Vyshnavi, Sai [1 ]
Sen, Supriya [1 ]
Sam, Thomas Shawn [1 ]
Cherian, Anish Jacob [1 ]
Daniel, Nirmal [2 ]
Paul, Mazhuvanchary Jacob [1 ]
机构
[1] Christian Med Coll & Hosp, Dept Endocrine Surg, Vellore, Tamil Nadu, India
[2] Christian Med Coll Vellore, Dept Pathol, Vellore, Tamil Nadu, India
关键词
Familial non medullary thyroid carcinoma (FNMTC); Cervical nodal recurrence in FNMTC; Genetic anticipation in FNMTC; BRAF V 600E positivity in FNMTC; CANCER;
D O I
10.1007/s13193-025-02214-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Familial non-medullary thyroid carcinoma (FNMTC) constitutes a minority of papillary thyroid carcinoma. An aggressive surgical strategy has been proposed in view of multifocality, invasiveness, nodal metastasis and higher recurrence rate. We present 4 affected family members, demonstrating aggressiveness and genetic anticipation. This study was conducted in a retrospective cohort of a family with 4 members affected with papillary thyroid carcinoma, diagnosed and treated between 2004 and 2023. The outcomes analysed were-age and stage at presentation, types of operation, histopathology, locoregional recurrence and follow-up. All the patients were female, with a mean age of 29.75 years (range 18-41 years). BRAF V600 E mutation was positive in 2/4 (50%). Besides thyroidectomy, central compartment lymph nodal dissection was done in 2/4 patients, while one patient also underwent selective lymph nodal dissection. Aggressive variant-diffuse sclerosing with hobnail features-was observed in 1/4 (25%). Lymphocytic thyroiditis was seen in 3/4 (75%). Residual thyroid required iodine ablation in 3/4 (75%). Nodal recurrence was seen in 2/4 (50%), requiring reoperation, with a mean time-to-recurrence of 7.5 years. We observed more aggressive behaviour, high risk variants, BRAF V 600E positivity, higher nodal recurrence and genetic anticipation in these 4 kindred.
引用
收藏
页数:4
相关论文
共 10 条
[1]  
[Anonymous], 2008, Endocr-Relat Cancer, V15
[2]   The Thyroid Gland: A Crossroad in Inflammation-Induced Carcinoma? An Ongoing Debate with New Therapeutic Potential [J].
Bozec, A. ;
Lassalle, S. ;
Hofman, V. ;
Ilie, M. ;
Santini, J. ;
Hofman, P. .
CURRENT MEDICINAL CHEMISTRY, 2010, 17 (30) :3449-3461
[3]  
Capezzone M, 2020, Long-term clinical outcome in familial and sporadic papillary thyroid carcinoma
[4]   On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds [J].
Charkes, ND .
THYROID, 2006, 16 (02) :181-186
[5]   Genetics of Familial Non-Medullary Thyroid Carcinoma (FNMTC) [J].
Diquigiovanni, Chiara ;
Bonora, Elena .
CANCERS, 2021, 13 (09)
[6]   Biological behavior and prognosis of familial papillary thyroid carcinoma [J].
Ito, Yasuhiro ;
Kakudo, Kennichi ;
Hirokawa, Mitsuyoshi ;
Fukushima, Mitsuhiro ;
Yabuta, Tomonori ;
Tomoda, Chisato ;
Inoue, Hiroyuki ;
Kihara, Minoru ;
Higashiyama, Takuya ;
Uruno, Takashi ;
Takamura, Yuuki ;
Miya, Akihiro ;
Kobayashi, Kaoru ;
Matsuzuka, Fumio ;
Miyauchi, Akira .
SURGERY, 2009, 145 (01) :100-105
[7]   Results of Screening in Familial Non-Medullary Thyroid Cancer [J].
Klubo-Gwiezdzinska, Joanna ;
Yang, Lily ;
Merkel, Roxanne ;
Patel, Dhaval ;
Nilubol, Naris ;
Merino, Maria J. ;
Skarulis, Monica ;
Sadowski, Samira M. ;
Kebebew, Electron .
THYROID, 2017, 27 (08) :1017-1024
[8]   An evidence-based approach to familial nonmedullary thyroid cancer: Screening, clinical management, and follow-up [J].
Sippel, Rebecca S. ;
Caron, Nadine R. ;
Clark, Orlo H. .
WORLD JOURNAL OF SURGERY, 2007, 31 (05) :924-933
[9]   Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population [J].
Uchino, S ;
Noguchi, S ;
Kawamoto, H ;
Yamashita, H ;
Watanabe, S ;
Yamashita, H ;
Shuto, S .
WORLD JOURNAL OF SURGERY, 2002, 26 (08) :897-902
[10]   Clinical Analysis of Familial Nonmedullary Thyroid Carcinoma [J].
Zhang, Qiang ;
Yang, Shuai ;
Meng, Xian-ying ;
Chen, Guang ;
Pang, Ren-zhu .
WORLD JOURNAL OF SURGERY, 2016, 40 (03) :570-573